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Abstract.  Rat microsomal aldehyde dehydrogenase 
(msALDH) has no amino-terminal  signal sequence, 
but instead it has a characteristic hydrophobic domain 
at the carboxyl terminus  (Miyauehi, K., R. Masaki,  S. 
Taketani,  A.  Yamamoto, A. Akayama, and Y.  Tashiro. 
1991. J.  Biol.  Chem.  266:19536-19542).  This mem- 
brane-bound enzyme is a useful model protein for 
studying posttranslational  localization to its final  desti- 
nation.  When expressed from eDNA in COS-1  cells, 
wild-type msALDH is localized exclusively in the 
well-developed ER.  The removal of the hydrophobic 
domain results in the cytosolic localization of trun- 
cated proteins,  thus suggesting that the portion is 
responsible for membrane anchoring.  The last 35 
amino acids of msALDH, including the hydrophobic 
domain,  are sufficient for targeting of E.  coli ~5-galac- 
tosidase to the ER membrane.  Further studies using 
chloramphenicol acetyltransferase fusion proteins sug- 
gest that two hydrophilie sequences on either side of 
the hydrophobic domain play an important role in ER 
targeting. 
great deal of attention  has been paid to resolve the 
mechanism for sorting  and targeting  of newly syn- 
thesized proteins to their final destinations,  and this 
is one of the fundamental problemsin cell biology.  Newly 
synthesized  proteins  are  destined  to  follow  two  distinct 
routes, depending  on the presence or absence of a signal se- 
quence at their amino termini  (37).  The signal recognition 
particle (SRP)  t in the cytosol recognizes  and binds to a sig- 
nal sequence of nascent peptides.  The resulting  SRP-ribo- 
some-nascent peptides complexes are targeted to the ER 
membrane through  their interactions  with the docking pro- 
tein  complex (35,  36).  After translocation  across the ER 
membrane, secretory and plasma membrane proteins follow 
a common pathway from the ER, through the Golgi complex, 
to the cell surface by default with bulk flow of lipids  (33). 
Resident proteins in the central vacuolar system are localized 
and retained in their final destinations  with the aid of either 
specific targeting  (18) or retention  signals  (25-27, 44). 
On the other hand,  proteins without a signal sequence at 
their amino termini  are synthesized  on free polysomes and 
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mM MgCI2; PDI, protein disulfide isomerase; PTP, protein tyrosine phos- 
phatase; STE, sucrose solution containing 10 mM Tris-HCl, pH 7.4, 1 mM 
EDTA, 10 t~g/ml leupepdn A, 0.5 mM PMSF, and 10 U/ml Trasyol; SRP, 
signal recognition particle. 
are posttranslationally  directed to intracellular  organdies 
such as mitochondria,  peroxisomes, the nucleus,  and the 
ER, or they remain in the cytosol. Much is known regarding 
targeting signals (14, 16, 39) and cytosolic protein factors (1, 
15) by which proteins are imported into these organelles. 
However, less is known regarding posttranslational  targeting 
of integral  membrane proteins to the outer mitochondrial 
membrane,  the peroxisomal membrane,  or the ER mem- 
brane. 
Cytochrome b5 has a hydrophobic  domain instead of an 
amino-terminal  signal  sequence  at  its  carboxyl  terminus 
(42).  For a long time,  cytochrome b5 has been noted to be 
a typical membrane protein inserted posttranslationally  into 
microsomal  membranes  through  the hydrophobic  domain. 
Besides, it has been reported that cytochrome b5 is localized 
in any membranes of intracellular  organdies, including  the 
ER membrane, the Golgi membrane, the plasma membrane, 
and the outer mitochondrial membrane (47).  Experiments 
using SRP-depleted  or -supplemented  in vitro systems have 
shown that this protein does not require SRP for insertion 
into microsomal membranes (3).  Therefore,  the carboxyl- 
terminal  hydrophobic  sequence was termed an "insertion" 
sequence through  which spontaneous integration  of cyto- 
chrome b5 into any exposed membranes could occur not 
only in vitro,  but also in vivo (5).  However, recent studies 
have shown that cytochrome b5 is restricted in the ER in vivo 
(11), and that the last 10 amino acids of this protein adjacent 
to the hydrophobic domain are important for its targeting to 
the ER (23). 
Recently,  we have  isolated and  sequenced a  full-length 
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(24). The deduced amino acid sequence of this enzyme pre- 
diets a similar molecular structure to that of cytochrome b5, 
a bulky amino-terminal domain without an amino-terminal 
signal sequence and a short hydrophobic domain at the car- 
boxyl terminus. We report here that msALDH is localized 
exclusively in the ER in COS-1 cells when expressed from 
cDNA, and that expression of this protein apparently alters 
the structure of the ER from a reticular to large vesicular 
one. In addition, we report that the hydrophobic domain is 
responsible for membrane anchoring and that msALDH is 
likely to have two ER targeting sequences on either side 
of the membrane anchoring domain. Our results suggest a 
novel mechanism for the posttranslational ER targeting of 
this tail-anchored protein. 
Materials and Methods 
Materials 
FBS was  purchased from Filtron Co.  (Brooklyn, Australia).  Penicillin- 
streptomycin  liquid was  from Gibco Laboratories (Grand Island, NY). 
DME was obtained from Nissui Pharmaceutical Co., Ltd. (Tokyo, Japan). 
Affinity-purified goat anti-rabbit IgG and anti-mouse IgG conjugated with 
TRITC were purchased from Protos Immunoresearch (San Francisco, CA). 
Affinity-purified goat anti-rabbit IgG and anti-mouse IgG conjugated with 
FITC were obtained from American Qualex Antibodies & Immunochemi- 
cals Co.  (La Mirada, CA).  FITC-eonjugated  wheat germ agglutinin was 
from E-Y Laboratories, Ine. (San Mateo,  CA). Affinity-purified goat anti- 
mouse IgG and anti-rabbit IgG conjugated with peroxidase were purchased 
from Dako A/S (Glostrup, Denmark) and Tago, Inc. (Burlingame,  CA), re- 
spectively.  Rabbit anti-chloramphenicol acetyltransferase  (CAT) antibody 
was obtained from 5 Prime~3 Prime, Inc. (Boulder, CO).  Mouse mAb to 
human mitochondria165-kD protein was from Chemicon International, Inc. 
(Temecula,  CA). Mouse mAbs to Escherichia  coil/5-galactosidase  and the 
/3-subunit of human prolyl 4-hydroxylase  were purchased from Boehringer 
Marmheim Biochemicals (Indianapolis,  IN) and Fiji Yakuhin Kogyo Co., 
Ltd. (Toyama, Japan), respectively. Since the/3-subunit  of prolyl 4-hydroxy- 
lase has been shown to be identical to protein disulfide  isomerase (PDI) 
(34), this mAb is referred to as PDI mAb in this paper.  Rabbit antibodies 
to rat msALDH,  NADPH-cytoehrome P-450 reductase (FP2), and PDI 
have been prepared and characterized as described (2, 21, 24). Rabbit an- 
tiserum to bovine mitochondrial complex HI was a generous gift from Dr. 
Takamasa Ozawa (Nagoya University, Nagoya, Japan). The eukaryotic assay 
vectors, pCH110 and pSV2CAT, were from Pharmaeia LKB Biotechnohigy, 
Inc.  (Uppsala, Sweden)  and Stratagene (La JoUa, CA), respectively.  The 
eukaryotic  expression vector pMIW (43) was kindly provided by Dr. Aki- 
hiro Inoue (National Institute for Physiological  Sciences,  Okazaki,  Japan). 
Restriction enzymes and DNA modifying enzymes were purchased from 
Nippon Gene (Toyama, Japan) and Takara Co., Ltd.  (Kyoto, Japan). All 
other chemicals were of the highest purity commercially available. 
Plasmid Constructions 
All constructions were verified by the dideoxy  chain termination method 
(38). Insertion of a full-length eDNA encoding rat msALDH into the unique 
EcoRI site of the SV-40-based vector pCD (30) has been described previ- 
ously (24).  The gapped duplex method of oligonueleotide-directed  muta- 
genesis (19) was used for truncation or deletion of msALDH eDNA. The 
full-length msALDH eDNA was cloned into the EcoRI site of M13tvl8 pre- 
pared from an umber mutant phage, and single-stranded phage DNA was 
purified for use as the template for mutagenesis.  Synthetic oligonueleotides 
used are termed as follows (with mutated nucleotides underlined): no. 1 (5' 
GGTCAGCTGATCGAAATTC 3'), no. 2 (5' CTCGTGTGATIU,-GTTGCG- 
GT 3'), no. 3 (5' GTGATCGTCTAGGATCAGC 3'), no. 4 (5' AAATTCTTC 
CTGCTGAACAAAGGAAGCd2TG 3'),  and no. 5 (5' CTGCTGAAACAG- 
TTCC~GC'ICd2TGCTTC  3').  The oligonueleotides  nos.  1, 2, and 3 
were used to generate sequences that included artificial  stop codons after 
amino acids 449, 470, and 480 of msALDH, respectively. The oligonucleo- 
tide no. 4 was used to produce the coding sequence for the mutant protein 
that lacked amino acids 457--459 of msALDH, and that for the mutant pro- 
tein lacking amino acids 460-463 was no. 5. After hybridization of the oli- 
gonucleotide  and a PvuII fragment derived from M13mpl8 with the tem- 
plate  DNA,  second-strand  synthesis  was  carried  out  with  T4  DNA 
polymerase and E. coil DNA ligase, and the resultant double-stranded DNA 
was transfected  into E. coil BMH71-18 routs for amplification.  Phages re- 
covered  from E.  coil BMH71-18 routs were then transfected into E.  coli 
MVI184 to select non-umber ones, and single-strunded  DNA from t~  to 
six plaques was sequenced to confirm the desired mutations.  The mutated 
cDNAs were excised from the double-stranded replicative form DNAs and 
cloned into the EcoRI site of the pCD vector.  The right orientation was 
verified by restriction enzyme digestion, and the resulting constructs were 
referred to as pCDALDHA450-484,  pCDALDHA471-484,  pCDALDHA- 
481-484,  pCDALDHA457-459,  and pCDALDHA460-463,  respectively. 
A chimeric eDNA for E.  coli/~-gaiactosidase  fusion protein was con- 
structed as follows. First, a DNA fragment encoding the earboxyl-terminal 
53 amino acids (amino acids 994-1046) of/5-galaetosidase,  followed by five 
amino acids (amino acids 450-454) of msALDH, was created by PCR using 
oligonuclcotides  no.  6  (5' AGCCATCGCCATCTGCTG 3') and no.  7  (5' 
GGAAGAATTTCGACCATrTTW_tACACCAGACC  3'). Similarly, a second 
DNA fragment corresponding to the last five amino acids  (amino acids 
1042-1046) of/5-galactosidase  followed by the last 35 amino acids (amino 
acids 450-484)  and 3' untranslated sequence of msALDH was amplified 
using oligonueleotides no. 8 (5' C_~'ICTC.~TG'IC_AAAAA'IUGTCGAAAT- 
TCTICC 3') and no. 9 with mutated nucleotides underlined for introduction 
of an EcoRI site (5' AACAACTTAGAATTCAC~GTTC 3'). These two 
fragments were then used as the templates to create a chimeric eDNA with 
the oligonucleotides  nos. 6 and 9. The resultant PCR fragment was digested 
with EcoRI and ligated in-frame to the EcoRI site (amino acids 1029-1030) 
of pCHII0 to construct pCHII0/ALDH. 
Since it was difficult to construct a series of various fusion genes using 
~-gaiactosidase  eDNA according to the method described above, we used 
CAT eDNA for further analyses on the role of the carboxyl-terminai  portion 
of msALDH in the intracellular localization.  Chimeric cDNAs for CAT fu- 
sion proteins (CAT/ALDH chimeras) were constructed essentially by com- 
bination of oligonucleotide-directed  mutagenesis and  PCR.  A  1.8-kbp 
HindHLBamHI eDNA fragment encoding CAT in the pSV2CAT was cloned 
into Ml3tvl8. Oligonuclnotides  no.  10 (5' AG~GGC~GGTACCT- 
AATTTTTTTA  3') and no.  11  (5' ATAAGTGATATCAAGCGGATGA 3') 
with mutated nucleotides  underlined were used for generation of a KpnI 
site at the carboxyl terminus and an EcoRV site in the 3' untranslated se- 
quence of CAT, respectively. The mutated eDNA was cloned into HindlH/ 
BamHI-digested  pMIW expression vector to construct pMIWCAT.  PCR 
was then used to generate DNA fragments corresponding to the carboxyl- 
terminal regions of msALDH, including the 3' untranslated sequence. PCR 
reactions  used  the  following  primers  and  templates to  amplify  DNA 
fragments termed ALDH1-7 and 9: ALDH1;  oligonueleotides  no.  12 (5' 
GAGTCCAAGGGTACCTGGTCGAAATTC  3') with mutated nueicotides 
underlined for introduction of a KpnI site and no. 9 (pCDALDH  as tem- 
plate), ALDI-I2; oligonucleotides  no.  12 and no. 9 (pCDALDHA481-484 
as  template),  ALDH3;  oligonucleotides  no.  13  (5' AAACAGTICAAC- 
GGTACCAGC~TGCAGCTG  3')  and  no.  9  (pCDALDH  as  template), 
ALDH4; oligonucleotides  no.  13 and no. 9 (pCDALDHA481-484  as tem- 
plate),  ALDH5;  oligonucleotides  no.  14  (5' GAAATTCTTCGGTACC- 
AAACAGTTCAAC 3') and no. 9 (pCDALDH as template), ALDH6; oligo- 
nucleotides no. 14 and no. 9 (pCDALDHA481-484  as template), ALDH7; 
oligonucleotides  no.  12 and no. 9 (pCDALDHA457-459  as template), and 
ALDH9; oligonucleotides  no.  12 and no. 9 (pCDALDHA460-463  as tem- 
plate).  These amplified fragments were then digested with KpnI and HpaI 
and ligated into the KpnI-EcoRV site of pMIWCAT. The resultant plasmids 
were designated pMIWCAT/ALDH1-7, and pMIWCAT/ALDH9,  respec- 
tively. For construction of pMIWCAT/ALDHS, pMIWCAT/ALDH2,  which 
has the unique PstI site in the coding sequence for the hydrophobic domain 
of  msALDH,  was  digested  with  PstI  and  BamHI,  and  ligated  into 
Pstl/BamHI digested  pMIWCATIALDH7.  Similarly,  the same fragment 
was  ligated  into PstI/BamHI digested  pM1WCAT/ALDH9  to  construct 
pMIWCAT/ALDH10. 
Cell Culture and Transfection 
COS-1 cells were maintained in DME with 10% FBS, 50 U/ml penicillin, 
and 50 ~g/ml streptomycin at 37"C  in a  5%  COz  incubator,  and were 
replated the day before transfection by trypsinization. Transfection was per- 
formed 4 h after the medium was replaced by the fresh one. For subeellniar 
fractionation experiments,  cells plated in a  lO0-mm  dish (50-70% con- 
fluem) were transfected with an expression plasmid (20 ~g) using the cai- 
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TGA 
S* 
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SWSKFFLLKOFNKGRLOLLLLV* 
+  +  +  + 
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+  +  +  + 
Figure 1. Deduced amino acid 
sequences of the carboxyl ter- 
mini of  wild-type  and  trun- 
cated forms of msALDH. The 
single  amino  acid  code  is 
used,  and  the  amino  acid 
numbers  of  msALDH  are 
shown  at  the  top.  Positively 
and negatively charged amino 
acids are marked +  and -  at 
the bottom, respectively. The 
hydrophobic  domains  are 
underlined.  The  eDNA  for 
msALDH  was  converted  to 
code for three truncated pro- 
teins,  msALDHA450-484, 
msALDHA471-484,  or  ms- 
ALDHA481-484  by  oligo- 
nucleotide-directed  mutagen- 
esis. 
cium phosphate precipitation method (48). For immunottuorescent experi- 
ments, cells were grown on a  22  ×  22-ram coverslip  in a  35-ram dish 
(10-20%  confluent)  and were transfected with 4  /~g plasmid DNA per 
35-mm dish. For immunogold localization  of CAT/ALDH chimeras, cells 
plated in a  60-ram dish (50-70% confluent) were transfected with 10 ttg 
plasmid DNA per dish. 4 h after application of DNA-calcium phosphate 
precipitate at 37°C, cells were shocked with 15% glycerol for 2 rain at room 
temperature, then incubated again at 370C for an additional 44 h before har- 
vesting for subcellular fractionation or fixation for indirect immunofluores- 
cence microscopy  or immunoelectmn microscopy. 
Subcellular Fractionation and Assays 
Cell fractionation was performed essentially as described previously for 
COS-I cells by Clark and Waterman (10) with slight modifications.  Briefly, 
cells were washed once with PBS and harvested in 5 ml of ice-cold 0.5 M 
sucrose containing 10 mM Tris-HCl, pH  7.4,  1 mM EDTA,  10 #g/ml 
leupeptin, 10/~g/ml pepstatin A, 0.5 m_M PMSF, and 10 U/ml Trasyol (0.5 
M STE).  After centrifugation at 800 g for 5 rain, the pellet was suspended 
in 0.5 ml of  0.5 M STE, homogenized with a Teflon-glass homogenizer, then 
diluted with an equal volume of 10 mM Tris-HCl, pH 7.4,  1 mM EDTA, 
10/tg/nd leupeptin,  10/=g/ml  pepstatin A, 0.5 mM PMSF,  and 10 U/rni 
Trasyol to obtain isotonic conditions. The total homogenate (designated H) 
was layered over 0.5 ml of 0.5 M STE and centrifuged at 800 g for 10 rain 
at 4°C using a swing but bucket, yielding a pellet (P1) consisting mainly 
of nuclei and unbroken cells. The supernatant and the interface were again 
layered over 0.5 M STE and centrifuged as above at 9,000 g for 10 min to 
isolate mitochondrial fraction (P2).  The resultant supernatant was  cen- 
trifuged at 88,000 g for 80 rain at 40C to sediment microsomal fraction (P3, 
mostly of the ER membrane). The final supernatant, consisting mostly of 
cytosol,  was  designated $3.  Membrane fractions,  P1,  P2,  and P3  were 
resuspended by hand homogenization in 0.25 M STE. Endogenous enzyme 
activities of FP2 (an ER marker) and succinate-cytochrome c reductase (a 
mitochondrial marker) were assayed by the methods of Omura and Takesue 
(31)  and  King  (17),  respectively.  Protein  was  measured  by  Bradford's 
method (7). 
Membrane Extractions 
Membrane fractions (100/tg protein) were resuspended in 0.8 ml of 100 
mM Na2CO3 (pH 11.5), and were incubated for 30 rain at 0*C (13). The 
suspension was then centrifuged at 88,000 g for 80 rain at 40C, and the pellet 
(P) was suspended in 100/~i of SDS-PAGE sample buffer (20). The superna- 
tant (S) was precipitated with 10% TCA, washed twice with 90% ethanol 
and once with diethyl ether, and dried. The resultant pellet was suspended 
in 100/d of SDS-PAGE sample buffer. 
Immunoblot Analysis 
All procedures were done at room temperature. Proteins were separated on 
8.5 % polyacrylamide gels (20) and electrophoretically  transferred to a dora- 
pore membrane according to the method of Burnette (8) using a semidry 
transfer blotter for 2.5 h at 36 V. After blocking with 3%  skim milk in 
TBS for 1.5 h, blots were incubated with primary antibody in 3 % skim milk/ 
TBS for 1.5 h, and washed four times (5 rain each) with 0.05% Tween-20 
in TBS.  They were then incubated with secondary antibody (pemxidase- 
conjugated  goat anti-rabbit IgG or anti-mouse IgG) in 0.05 % Tween-20/ 
TBS for 1.5 h, followed by four washes (5 rain each) with 0.05% Tween- 
20/TBS.  Blots were stained using the enhanced chemiluminescence West- 
ern blotting detection system (Amersham Corp., Arlington Heights,  IL). 
Protein bands were quantitated using an enhanced laser densitometer (LKB 
Instruments Inc., Bromma, Sweden) to evaluate the relative level of proteins 
in each subcellular fraction. The densitometric scan value was then esti- 
mated by multiplying the relative level by the protein yield (milligrams of 
protein) in corresponding subcellular fraction. In calculating the percent 
distribution of each immunodetectable protein,  the densitometric scan 
value of the homogenate was defined as 100%. 
Indirect Immunofluorescence Microscopy 
All  procedures,  except  for  the  incubation  with  antibodies  or  FITC- 
conjugated lectin at 37°C,  were carried out at room temperature.  Cells 
grown on coverslips were washed gently three times (5 rain each) with PBS, 
fixed with 4% paraformaldehyde  in PBS containing 1 mM CaC12 and 0.5 
mM MgCI2 [PBS(+)] for 20 rain, and permeabilized with 0.1% Triton 
X-100 in PBS(+) for 1 h. They were then rinsed twice with PBS(+), and 
incubated with 2 % FBS in PBS(+) to block nonspecific binding of primary 
antibodies for 1 h followed by 45 rain incubation with primary antibody in 
2 % FBS/PBS(+). After washing four times (5 rain each) with PBS(+), cells 
were incubated with secondary antibody in 2% FBS/PBS(+) for 45 min. 
For localization  of the Golgi complex, cells were incubated with FITC- 
conjugated wheat germ agglutinin in 2% FBS/PBS(+) for 45 rain. After 
washing with PBS(+), they were then mounted on glass slides with 90% 
glycerol in PBS containing 1 m~/ml paraphenylenediamine, examined,  and 
photographed on a microscope (BH-2; Olympus Corp., Tokyo, Japan) with 
Ektachrome 400 film (Kodak,  Rochester,  NY). 
Immunoelectron Microscopy on Frozen 
Ultrathin Sections 
Frozen  ultramicrotomy was performed as described  by  Tokuyasu (46). 
Transfected cells were harvested by centrifugation at 1,000 g for 3 rain, and 
the pellet  was fixed with 4% paraformaldehyde and 0.1% glutaraldehyde dis- 
solved in 0.1 M cacodylate buffer, pH 7.4, for 15 min. Small pieces of the 
fixed pellets of COS-I cells were incubated overnight in O.l M sodium phos- 
phate buffer, pH 7.4, containing 2.3 M sucrose and 20% polyvinyl pyrroli- 
done, and were rapidly frozen in liquid propane at -180°C. Frozen ultrathin 
sections were cut with an ul~cmtome  (Ultracut-N; Reichert,  Wien, 
Australia) with a cryoattachment  (FC-4D;  P~ichert).  The sections were 
picked up on formvar-carbon-conted  nickel grids, incubated with 2 % gela- 
tin in PBS containing lO ~  glycine, then reacted with anti-CAT antib(xiy 
or control IgG prepared from a nonimmunized rabbit serum. The sections 
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msALDH. (A) COS-1 cells were transfected with cDNA for wild- 
type or truncated forms of msALDH in the pCD vector, and were 
harvested 44 h after transfection. Equal amounts of protein (20/~g) 
from each homogenate were resolved on SDS-PAGE and immuno- 
blotted using anti-msALDH  antibody. Lane 1, msALDH; lane 2, 
msALDHA481-484; lane 3, msALDHA471-484; lane 4, msALDH- 
A450-484. (B) Subcellular fractions (P1, P2, P3, and $3) were iso- 
lated  from each homogenate  (H) as described  in Materials  and 
Methods, and equal amounts of protein (12 #g, except for 6 #g of 
subcellular fractions from cells expressing msALDH or msALDH- 
A481-484) were immunoblotted using anti-msALDH antibody. En- 
dogenous FP2 and mitochondrial Rieske iron-sulfur protein (ISP) 
of the complex III were detected using anti-FP2 antibody and anti- 
complex III antiserum,  respectively. (C) The percent distribution 
in  each  subcellular  (P1, P1, P3, and  $3)  fraction  is  shown for 
msALDH, three truncated proteins,  FP2, or ISP. The distribution 
of immunodetectable proteins in each subcellular fraction was cal- 
culated as described in Materials and Methods. In calculating the 
percent  distribution,  the densitometric  scan value of the homog- 
enate (H) was defined as 100%. The bars show the mean +  SD 
(n  =  3). 
were then washed six times with gelatin solution, and were reacted with goat 
anti-rabbit  IgG  gold  conjugate  (10  nm  in  diameter)  (British  BioCell, 
Cardiff, UK). After washing with sodium cacodylate buffer, pH 7.4, sec- 
tions were postfixed in 2% glutaraldehyde, then in 1% OsO4, stained with 
uranyl acetate, embedded in LR white resin (Bio Rad Microscience Divi- 
sion, Watford, UK), and observed with an electron microscope (H-7000; 
Hitachi, Tokyo, Japan). 
Table I.  Distribution  of FP2, Succinate-Cytochrome  c 
Reductase,  and Protein  in Subcellular  Fractions 
FP2  SCR  Protein 
(%)  (%)  (%) 
H  100  100  100 
P1  6  +  3  9  +  2  10  +  4 
P2  12  +4  48  +  2  12  +  3 
P3  42  +  8  7  +  3  21  +  3 
$3  7  +  1  0  +  0  39  +  6 
Cell fractionation was performed as described in Materials and Methods. In 
calculating the percent distribution, each value of the homogenate was defined 
as 100%.  The distribution of FP2 and succinate-cytochrome  c reductase(SCR) 
is determined from the specific  activities measured. The specific  activities of 
the homogenate fractions are 52.3 +  11.0 nmol cytechrome c reduced/rain per 
mg protein  (the mean  +  SD n  =  4)  and 26.9  +  2.8  nmol cytoehrome c 
reduced/min per mg protein for FP2 and succinate-cytochrome c reductase, 
respectively. 
Results 
Construction of Truncated Mutants of msALDH 
In the previous study (24), we cloned and sequenced the full- 
length  cDNA  for rat msALDH.  The nucleotide  sequence 
predicts  a  polypeptide of 484  amino acids,  and  the  most 
characteristic  feature  of this  membrane-bound  ALDH  is 
carboxyl-terminal 35 amino acids, consisting of a  stem re- 
gion  (amino  acids  450-463)  and  a  hydrophobic  domain 
(amino acids 464-480)  followed by a  short hydrophilic tail 
region (amino acids 481-484) as shown in Fig.  1.  Since rat 
cytosolic tumor-associated ALDH, which is 65.5 % identical 
to msALDH (24),  lacks the carboxyl-terminal portion, we 
asked whether this portion played an important role in the 
intracellular localization of msALDH. For this purpose, we 
constructed three mutant proteins truncated at either amino 
acid  450  (msALDHA450-484,  which  corresponds  to  the 
tumor-associated ALDH in size), 471  (msALDHA471-484, 
deletion of more than half of the hydrophobic domain to- 
gether with the tail region), or 481 (msALDHA481-484, de- 
letion of solely the tail region) by oligonucleotide-directed 
mutagenesis (Fig.  1). 
These mutant proteins and wild-type msALDH were ex- 
pressed transiently in COS-1 cells under the control of SV-40 
promoter in the pCD expression vector. This transient ex- 
pression system in COS-1 cells was chosen as the most rapid 
method  for evaluating the  intracellular  localization  of ex- 
pressed proteins.  Cells were allowed to express these pro- 
teins for 44 h,  harvested, and the expressed proteins were 
analyzed by immunoblotting using anti-msALDH antibody. 
As shown in Fig. 2 A, msALDH and three truncated proteins 
were expressed efficiently in the total homogenates. As ex- 
pected,  molecular  masses  of the  truncated  proteins  were 
smaller than that of msALDH (54 kD). In addition, no cross- 
reactive protein was detected in untransfected COS-1  cells 
(data  not  shown),  indicating  the  absence  of endogenous 
msALDH. These results allowed us to investigate the intra- 
cellular  localization  of msALDH  by  transfection  experi- 
ments. 
Deletion of the Carboxyl-terminal Portion of 
msALDH Abolishes ER Localization 
We analyzed the intraceUular distribution of msALDH and 
three truncated proteins by subcellular fractionation accord- 
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association of wild-type msALDH and two truncated proteins. (,4) 
Each P3 fraction was treated with 100 mM Na2CO3 for 30 rain at 
0°C, and centrifuged at 88,000 g for 80 min to separate the pellets 
(P)  from the  supernatants  (S).  The distribution  of msALDH, 
msALDHA481-484, msALDHA471-484, FP2, or PDI in the P and 
S fractions was assayed by immunoblotting. Polyclonal anti-PDI 
antibody was used for immunodetection of endogenous PDI.  (B) 
The relative level of each protein in the P and S fractions was quan- 
titated by a scanning densitometer. In calculating portions recov- 
ered in the P fraction, the total level of each protein recovered in 
the P and S fractions was defined as 100 %. The bars show the mean 
+  SD (n =  3). 
ing to the method of Clark and Waterman (10).  The separa- 
tion of ER membranes from mitochondria was checked by 
assaying two typical marker enzymes, FP2 (NADPH-cyto- 
chrome P-450 reductase), which has been shown to be an in- 
tegral  ER  membrane  protein  (22),  and  a  mitochondrial 
marker succinate-cytochrome c reductase. As shown in Ta- 
ble I, FP2 and succinate-cytochrome c reductase were en- 
riched in the P3 fraction and the P2 fraction, respectively. 
In addition, when equal amounts of protein were immuno- 
blotted, the highest levels of FP2 and mitochondria Rieske 
iron-sulfur protein were found inthe P3 fraction and the P2 
fraction, respectively (Fig. 2 B). The percent distribution of 
the two proteins in each subcellular fraction also confirmed 
a  good  separation  of ER  membranes  from mitochondria 
(Fig.  2  C).  The subceUular distribution of msALDH and 
msALDHA481-484 was almost identical to that of FP2 (Fig. 
2, B and C), suggesting the ER localization of these proteins 
in transfected COS-1  cells.  On the other hand,  msALDH 
A450-484 was found exclusively in the $3 fraction. This re- 
sult  indicated that the mutant protein lacking the last  35 
amino acid8 of msALDH was no longer associated with in- 
tracellular membranes. Curiously, msALDHA471-484 was 
recovered not only in the $3 fraction, but also in the P3 frac- 
tion, showing an intermediate distribution between msALDH 
and msALDHA450-484. 
We explored the nature of the association of the expressed 
proteins with microsomal membranes.  Upon treatment of 
the P3 fraction with 100 mM Na2CO3 (pH 11.5) (13), FP2 
(the integral ER membrane protein) remained attached to 
microsomal membranes as judged by immunoblotting (Fig. 
3, A and B). Wild-type msALDH and msALDI-I~481-484 
were also resistant to alkali extraction, although ,x,35 % of 
msALDHA481-484 was  released.  Under the same  condi- 
tions, >80% of msALDHA471-484 and PDI (a luminal ER 
residen0  were released,  indicating  a  loose association of 
these proteins with microsomal membranes. Similar results 
were obtained upon Triton X-114 cloud point extraction (6) 
(data not shown). These data, together with those from sub- 
cellular fractionation, suggested that the carboxyl-terminal 
portion of msALDH including the hydrophobic sequence 
(amino acid 464-480) was necessary for both its ER localiza- 
tion and the tight association with the ER membrane. 
We next determined the intracellular localization of  msALDH 
and  the  truncated proteins using  indirect immunofluores- 
cence microscopy. Cells transfected with cDNAs in the pCD 
vector were fixed and permeabilized 44 h after transfection, 
and the expressed proteins were detected by incubation with 
anti-msALDH antibody followed by TRITC-conjugated sec- 
ondary antibody. As shown in Fig. 4 A, anti-msALDH anti- 
body stained a number of large vesicular structures that sur- 
rounded the nucleus, in addition to diffuse reticular ones in 
COS-1 cells transfected with msALDH eDNA. No staining 
was seen at the plasma membrane and in the nucleoplasm. 
A similar pattern of staining for msALDH was observed ei- 
ther 24 h after transfection in COS-1 cells or when expressed 
in HeLa cells or baby hamster kidney cells (data not shown). 
To explore this strange structure in more detail, we used dou- 
ble  indirect  immunofluorescence  microscopy  using  two 
mAbs or FITC-conjugated lectin. Expressed msALDH was 
found to colocalize with endogenous PDI (Fig. 4 B, arrow), 
although  PDI  displayed a  characteristic reticular staining 
pattern in cells not expressing msALDH (Fig. 4 B, arrow- 
head). In contrast, msALDH colocalized neither with a mi- 
tochondrial 65-kD protein (Fig. 4,  C and D) nor with the 
perinuclear Golgi complex visualized by FITC-conjugated 
wheat  germ  agglutinin  (Fig.  4,  E  and  F).  These results 
strongly suggest the ER localization of msALDH and the 
drastic morphological change of the ER by expression of 
msALDH.  A  similar  ER  staining  pattern  was  observed 
for msALDHA481-484  (Fig.  4,  G  and H),  whereas both 
msALDHA471-484 and msALDHA450-484 were found dis- 
tributed diffusely throughout the cytoplasm, and they did not 
colocalize with PDI (Fig. 4, I-L).  In addition, a significant 
amount of msALDHA450-484 appeared to enter the nucleus 
(Fig.  4  K).  These  immunolocalization data  were consis- 
tent with those  from subcellular fractionation,  suggesting 
strongly the important role of the carboxyl-terminal portion 
of msALDH in its ER localization. 
The Carboxyl-Termina135 Amino Acids of msALDH 
Are Sufficient for ER Localization 
We  focused our  attention  on the  role  that  the  carboxyl- 
terminal portion of msALDH might play in ER targeting, 
and we asked whether this portion could direct a heterolo- 
gous protein to the ER membrane. For this purpose, we con- 
structed an expression plasmid shown in Fig. 5 A. The con- 
trol vector (pCHll0) contains E. coli/3-galactosidase,  which 
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msALDH and three truncated pro- 
reins  in transfected  cells  by double 
indirect immunofluorescence micros- 
copy.  COS-1 cells grown on cover- 
slips  were  transfected  with  pCDA- 
LDH  (A-F),  pCDALDHA481-484 
(G and H), pCDALDHA471-484 (I 
and J) or pCDALDHA450-484, (K 
and  L),  fixed  44  h  after  transfec- 
tion,  and permeabilized.  Wild-type 
msALDH (A, C, and E) and the trun- 
cated proteins  (G,  I,  and  K)  were 
then  detected  by  incubation  with 
anti-msALDH antibody followed by 
TRITC-conjogated  secondary  anti- 
body.  For  visualization  of endog- 
enous PDI (B, H, 1, and L) or a mito- 
chondrial 65-kD protein (D), cells 
were  stained  with  corresponding 
mAbs followed by FITC-conjugated 
secondary antibody. The Golgi com- 
plex was localized by staining  with 
FITC-conjugated wheat germ agglu- 
tinin (F).  The arrow in B/indicates 
COS-I  cell  expressing  msALDH, 
whereas the arrowhead in the same 
figure indicates the cell that does not 
express  msALDH. 
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Figure 5.  Immunoblot  analysis of #-galactosidase  and  /~-galac- 
tosidase/ALDH  in transfected cells.  (A) Schematic diagrams of 
msALDH,/~-galaetosidase,  and #-galactosidase/ALDH in the ex- 
pression vectors are shown. SV-40 implies the SV-40 early pro- 
moter. The expression plasmids pCDALDH, pCHll0, and pCHll0/ 
ALDH contain msALDH, E. coil B-gaiactosidase, and/5-gaiacto- 
sidase/ALDH, respectively. The amino acid numbers of each pro- 
tein are shown at the top, and the relevant restriction endonuelease 
sites are at the bottom. E, EcoRI; H, HindIH; B, BamI-H. The last 
35 amino acids of msALDH are indicated by the solid bar. The chi- 
meric eDNA fragment with EcoRI sites shown by the bar was am- 
plified by PCR and cloned in-frame to the unique EcoRI site in 
pCHll0 as described in Materials and Methods. To the right, the 
intracellular location of each protein is noted as E for ER or C for 
cytosolie. (B) COS-1 cells were transfected with pCHll0 (~Gal) 
or pCHll0/ALDH ~3GaI-ALDH), and harvested 44 h after trans- 
fection. The membrane (P) and cytosol (S) fractions were prepared 
by centrifugation of the postnuelear fractions at 88,000 g for 80 
i rain. The membrane fraction containing/3GaI-ALDH was treated 
• with 100 mM Na2CO3 at 0*C for 30 min, and was centrifuged at 
88,000 g for 80 min to separate the pellet (P) from the supernatant 
(S). Each fraction was assayed by immunoblotting using mAb to 
/3-galactosidase. 
was supposed to remain in the cytoplasm when expressedin 
COS-1  cells under the control of the SV-40 promoter. The 
constructed expression plasmid (pCHll0/ALDI-I) contains 
the last 35 amino acids of msALDH cloned in-frame to the 
3' end of/3-galactosidase. COS-1 cells were transfected with 
these DNAs and subjected to a crude subcellular fraction- 
ation.  In  this  case,  the postnuclear  supernatant was  cen- 
trifuged at 88,000 g  for 80 min to separate the membrane 
fraction  (P,  containing  mostly  mitochondria  and  micro- 
somes) from the cytosol fraction (S). Immunoblotting using 
mAb  to  E.  coli  ~-galactosidase  revealed  that  wild-type 
~-galactosidase was recovered, as expected, in the S frac- 
tion,  whereas  ~-galactosidase/ALDH  chimera was  found 
concentrated in the P fraction (Fig. 5 B). In addition, the chi- 
mera in the P fraction was resistant to alkali extraction, indi- 
caring a fight anchoring of this protein to intracellular mem- 
branes (Fig.  5 B). 
Indirect  immunofluorescence  microscopy  showed  that 
~-gaiactosidase  was  distributed  diffusely  throughout  the 
cytoplasm (Fig. 6 A). However, attachment of the carboxyl- 
terminal  35  amino  acids  of msALDH to  ~-galactosidase 
resulted in the reticular pattern of staining that surrounded 
the nucleus and extended throughout the cytoplasm (Fig. 6 
B). Double indirect immunofluorescence microscopy using 
polyclonal anti-PDI antibody showed the colocalization of 
/3-galactosidase/ALDH chimera and PDI in the ER (Fig. 6 
C).  These results suggested that the carboxyl-terminai 35 
amino acids were sufficient for targeting of E. coli #-galac- 
tosidase to the ER membrane. 
Both Stem and Tail Regions of msALDH Contain 
ER-targeting Sequences 
We attempted to define the sequence requirement for ER tar- 
geting within the last 35 amino acids of msALDH, which is 
composed of three regions as shown in Fig.  l, and we con- 
structed a series of CAT/ALDH chimeras (CAT/ALDH1-4) 
(Fig. 7).  CAT/ALDH1 contains the last 35 amino acids of 
msALDH  at  the  carboxyl terminus  of CAT,  while  CAT/ 
ALDH2-4  chimeras  lack  either  the  tail,  stem,  or  both 
regions  of msALDH.  COS-1  cells  were transfected with 
these cDNAs in the pMIW expression vector that possesses 
/3-actin  promoter and  Rous  sarcoma enhancer.  The intra- 
cellular localization of the expressed proteins were deter- 
mined by indirect immunofluorescence microscopy using 
anti-CAT antibody. Wild-type CAT was distributed, as ex- 
pected, throughout the cytoplasm. In addition, it was also 
detected in the nucleoplasm (Fig. 8 A). CAT/ALDH1 showed 
the characteristic ER staining pattern (Fig. 8 B), which was 
confirmed by double indirect immunofluorescence micros- 
copy using PDI mAb (Fig. 8 C). This result was similar to 
that obtained with/5-gaiactosidase/ALDH (Fig. 6, B and C). 
Both CAT/ALDI-I2  and  CAT/ALDH3  were also  found to 
colocalize with endogenous PDI in the ER (Fig. 8, D-G). 
On the other hand, CAT/ALDH4 containing only the hydro- 
phobic domain of msALDH at its carboxyl terminus showed 
a similar pattern of staining to that of wild-type CAT. This 
chimera  remained  not only in  the  cytoplasm,  but  in  the 
nucleoplasm as well (Fig. 8 H), and it did not colocaiize with 
PDI (Fig. 8 I). The simplest interpretation of these results 
is that both the stem and tail regions appear to contain ER- 
targeting information of msALDH. 
To  elucidate  more  narrowly  the  sequence  requirement 
within the stem region for ER targeting, we constructed an 
additional series of CAT/ALDH chimeras (CAT/ALDH5-10) 
(Fig. 9), in which three to seven amino acids of the stem re- 
gion of either CAT/ALDH1  or  CAT/ALDI-I2  are deleted. 
The intracellular localization of these chimeras expressed in 
COS-1  cells was analyzed by indirect immunofluorescence 
microscopy. Three chimeras, CAT/ALDH5, CAT/ALDH7, 
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by virtue of the tail region, even if they lack an ER targeting 
sequence within the stem region, and indeed they showed the 
reticu~lar  staining  pattern including  the  nuclear membrane 
(Fig.  10, A, C, and E). Among the mutant proteins lacking 
the tail region, CAT/ALDH6 and CAT/ALDH10 showed the 
reticular pattern (Fig. 10, B and F). These reticular compart- 
ments were confirmed to be the ER by colocalization with 
PDI  (data  not  shown).  In  contrast,  CAT/ALDH8,  which 
lacks  the  Lys-Gln-Phe  sequence  (amino  acids  457-459) 
within the  stem region and the tail region,  was found dis- 
tributed diffusely throughout the cytoplasm and the nucleo- 
plasm (Fig.  10 D). 
Figure 6.  Localization of fl-galacto- 
sidase  and  fl-galactosidase/ALDH 
in transfected  cells by double  indi- 
rect immunofluoresc~nce  microscopy. 
COS-I  cells  were  transfected  with 
pCHll0  (A)  or pCHll0/ALDH (B 
and C), fixed 44 h after transfection, 
and permeabilized,  mAb to fl-galac- 
tosidase was used to stain fl-galacto- 
sidase (A) or fl-galactosidase/ALDH 
(B).  Polyclonal  anti-PDI  antibody 
was used for detection of  endogenous 
PDI (C). 
We investigated in more detail the intracellular localiza- 
tion of CAT and CAT/ALDH chimeras in transfected COS-1 
cells using an IgG-gold immunoelectron microscopic tech- 
nique on frozen ultrathin sections. Gold particles were dis- 
tributed in the cytoplasm and in the nucleoplasm in COS-1 
cells transfected with pMIWCAT (Fig.  11 A). A similar dis- 
tribution of gold particles was observed in COS-1 cells ex- 
pressing  either  CAT/ALDH4  (data  not  shown)  or  CAT/ 
ALDH8 (Fig. 11 D). In marked contrast, gold particles were 
predominantly detected on the cytoplasmic surface of the ER 
membrane in COS-1 cells expressing CAT/ALDH1 (Fig.  11 
B),  CAT/ALDH7  (Fig.  11  C),  or  the  other  CAT/ALDH 
chimeras (data not shown).  These immunoelectron micro- 
1  CAT  21 9 
sv  c  CAT 
H  K  V  B 
450  484 
CAT/ALDH1  ~  gSKFFLLKOFNKGRLQLLLLVCLVAVAAV  I VKDOL--  E 
450  480 
CAT/ALDH2  ~  WSKFFLLKOFNKGRLQLLLLVCLVAVAAV  I V  E 
463  484 
CAT/ALDH3  ~  .................................. RLQLLLLVCLVAVAAV I VKDOL--  E 
463  480 
CAT/ALDH4  ~  .................................. RLOLLLLVCLVAVAAV I V  C 
•  Figure  7. Schematic diagrams of CAT and CAT/ALDH1-4 chimeras  in the pMIW expression vector. /3-actin and RSV mean the fl-actin 
promoter and Rous sarcoma enhancer, respectively. The coding sequence of CAT is indicated by the solid bar. The single amino acid code 
is used to represent the carboxyl-terminal sequences ofmsALDH. Deleted sequences are indicated by broken lines. The amino acid numbers 
of each protein are shown at the top, and the relevant restriction  endonuclease  sites at the bottom. H, HindHI; K, KpnI;  V, EcoRV; B, 
BamHI. To the right,  the intracellular  location of each protein  is noted as E for ER or C for cytosolic. 
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CAT/ALDH1-4 chimeras  in  trans- 
fected cells by double indirect immu- 
nofluorescence  microscopy.  COS-1 
cells  were  transfected  with  pMIW- 
CAT (A), pMIWCAT/ALDH1 (B and 
C), pMIWCAT/ALDH2 (D and E), 
pMIWCAT/ALDH3 (F and  G),  or 
pMIWCAT/ALDH4 (H and I), fixed 
44 h after transfection,  and perme- 
abilized.  Wild-type  CAT  (A)  and 
CAT/ALDH chimeras  (B, D, F,, and 
H) were detected by anti-CAT anti- 
body. Endogenous PDI (C, E, G, and 
I) was stained with mAb to PDI. 
scopic data are consistent with indirect immunofluorescent 
data,  and these immunolocalization data together strongly 
suggest that the ER-targeting sequences of msALDH exist 
within  the  Lys-Gln-Phe sequence  in  the  stem region  and 
within the Lys-Asp-Gln-Leu sequence of the tail region. 
Discussion 
Expression of msALDH in COS-1 Cells Alters 
the ER Structure 
We have shown here by subcellular fracfionation and indirect 
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457  480 
CAT/ALDH6  --~-  ................... KOFNKGRLOLLLLVCLVAVAAV I V  E 
450  456  460  484 
CAT/ALDH7  --~WSKFFLL  .........  NKGRLOLLLLVCLVAVAAVIVKDOL--  E 
450  456  460  480 
CAT/ALDH8  ~WSKFFLL  ........  NKGRLOLLLLVCLVAVAAVIV.  C 
450  459  464  484 
CAT/ALDH9  ~WSKFFLLKOF  ............  LOLLLLVCLVAVAAVIVKDOL--  E 
450  459  464  480 
CAT/ALDHIO  ~WSKFFLLKOF  ...........  LOLLLLVCLVAVAAVIV-  E 
Figure 9. Schematic diagrams of CAT/ALDH540 chimeras in the pMIW expression vector. The coding sequence of CAT is indicated by 
the solid bar. The single amino acid code is used to represent the carboxyl-terminal  sequences of  msALDH. Deleted sequences are indicated 
by broken lines. The amino acid numbers of each protein are shown at the top. To the right, the intracellular location of each protein is 
noted as E  for ER or C for cytosolic. 
immunofluorescence experiments that not only msALDH, 
but also msALDHA481-484, colocalizes with two ER marker 
proteins,  FP2  and  PDI,  when expressed from cDNAs  in 
COS-1 cells. Surprisingly, indirect immunofluorescence mi- 
croscopy revealed the apparent alteration of  the ER structure 
in cells expressing either msALDH or msALDH-A481-484. 
The altered ER structure was characterized by large vesicu- 
lar structures mainly located near the nucleus. Since the un- 
usual  staining  pattern  was  observed  by  expression  of 
msALDH or msALDHA481.484, it appeared that the ER an- 
Figure  10.  Localization  of  CAT/ 
ALDHS-10 chimeras in transfected 
cells by indirect immunofluorescence 
microscopy. COS-1 cells were trans- 
fected with pMIWCAT/ALDH5 (A), 
p~T/ALDH6  (B), pM~CAT/ 
ALDH7  (C),  pMIWCAT/ALDH8 
(D),  pM1WCAT/ALDH9  (E),  or 
pM1WCAT/ALDHI0 (F), fixed 44 h 
after  transfection,  permeabilized, 
and stained with anti-CAT antibody. 
The Journal of Cell Biology,  Volume 126, 1994  1416 Figure 11. Immunogold electron microscopic localization of CAT and CAT/ALDH chimeras in transfected cells. COSol cells were trans- 
fected with pMIWCAT (A), pMIWCAT/ALDHI (B), pMIWCAT/ALDH7 (C), or pMIWCAT/ALDH8 (D), and fixed  44 h after transfection. 
Ultrathin cryosections of COS-1 cells were reacted with anti-CAT antibody and subsequently with goat anti-rabbit IgG gold conjugate (10 
nm in diameter). ER,  endoplasmic reticulum; G, Golgi apparatus; PM, plasma membrane; N, nucleus. Bar, 500 nm. choring of these proteins led to the morphological alteration 
of the ER. We are now investigating in more detail the al- 
tered ER structure by immunoelectron microscopy, and we 
have recently found that the ER tubules in COS-1  cells ex- 
pressing msALDH are packed in crystalloid hexagonal arrays 
(Yamamoto, A., R. Masaki, and Y. Tashiro, manuscript in 
preparation).  The elucidation of the altered ER  structure 
would provide interesting information on the morphological 
change of the intracellular organelle induced by overexpres- 
sion of a resident membrane protein. 
ER-targeting  Sequences of msALDH Are Located at 
Its Carboxyl Terminus 
We showed previously that msALDH has no amino-terminai 
signal sequence, but instead, that it has a longer carhoxyl- 
terminal  portion  than  cytosolic tumor-associated  ALDH 
(24). Our truncation and domain replacement experiments 
have shown here that the last 35 amino acids of msALDH 
are  necessary  for  its  ER  localization  and  also  sufficient 
enough for localization of two beterologous proteins, E. coli 
/~-galactosidase and CAT, to the ER. We therefore conclude 
that the carboxyl-terminal portion contains an ER-targeting 
sequence of msALDH. 
Further analyses on the intraceilular distribution of vari- 
ous  CAT/ALDH chimeras  have defined the  ER targeting 
sequence ofmsALDH. Both CAT/ALDH4 and CAT/ALDH8 
were distributed in the cytoplasm and nucleoplasm similar 
to wild-type CAT in spite of  possessing the whole hydropho- 
bic domain (amino acids 464-480) of msALDH at their car- 
boxyl termini, whereas the other chimeras were predomi- 
nantly localized to the ER. The two chimeras are lacking the 
Lys-Gln-Phe sequence within the stem region and the Lys- 
Asp-Gln-Leu sequence of the tail region,  thus suggesting 
that both sequences represent the ER-targeting sequences 
of msALDH.  We are  now in  the process of determining 
through mutagenesis  which amino acids  within these two 
regions are required for ER targeting. On the other hand, 
it seems likely that the hydrophobic sequence of msALDH 
functions mainly as the ER membrane anchor because this 
portion is essential for membrane anchoring. 
To the best of our knowledge, our data characterize the 
first intracellular protein that appears to have two targeting 
sequences separated by a membrane anchor. The ambiguous 
behavior of msALDHA471-484 could be explained as fol- 
lows. A portion of this truncated protein could be targeted 
to the ER by virtue of the Lys-Gln-Phe sequence within the 
stem region, hut because of the shortened hydrophobic do- 
main, the portion would he either released into the cytosol 
or maintain only a loose association with the membrane. 
The significance of  the presence of  two separated targeting 
sequences is not yet clear. A small portion of  msALDHA481- 
484 was, in fact, recovered in the $3 fraction, whereas only 
insignificant amounts of msALDH or FP2 (Fig. 2, B and C), 
which is efficiently targeted to the ER through the amino- 
terminal signal sequence, were recovered in the $3 fraction. 
Therefore, it is likely that the presence of two targeting se- 
quences in the same protein might be a  means to ensure 
the more efficient ER localization of msALDH. In addition, 
the hydrophilic tail region might also serve to increase the 
strength of the membrane anchoring,  as  indicated by the 
partial  membrane  extraction  of msALDHA481-484  with 
Na2CO3 (Fig.  3).  Although it is not yet clear whether the 
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Figure 12. Possible mechanisms for ER targeting of msALDH. (A) 
Alignment of the  sequences of the carboxyl-terminal 35 amino 
acids of human PTP 1B (amino acids 401-435) (9), rat cytochrome 
b5 (amino acids 99-134) (32), and rat msALDH (amino acids 450- 
484) (24). The single amino acid code is used. Positively and nega- 
tively charged amino acids are marked + and -  at the top, respec- 
tively. Each hydrophobic domain is underlined and the ER targeting 
sequences of either cytochrome b5 (23) or msALDH are indicated 
by broken  lines.  (B) Two possible models for ER targeting of 
msALDH.  In model I, the aggregation of the newly synthesized 
msALDH  polypeptides  in  the  cytoplasm  is  prevented  by  the 
hydrophilic ER targeting sequences adjacent to the hydrophobic an- 
choring  sequence. The monomeric msALDH would be inserted 
into the ER membrane with the aid of a receptor protein on the ER 
membrane. In model II, the complex of msALDH and a cytosolic 
•  receptor protein would be targeted to the ER, and msALDH would 
be inserted  correctly  into  the ER membrane  spontaneously or 
through the interaction with a receptor protein on the membrane. 
hydrophobic segment fully transverses the membrane, this 
transmembrane disposition seems more likely to explain the 
tight anchoring of the protein in the ER membrane than a 
loop model where the hydrophilic tail remains on the cyto- 
plasmic surface. 
The Lys-Asp-Gln-Leu sequence of the tail region strongly 
resembles the well-characterized Lys-Asp-Glu-Leu retention 
signal found in the ER luminal proteins (25), suggesting that 
the Lys-Asp-Gln-Leu sequence, if translocated into the lu- 
men of  the ER, serves as an ER retention signal of  msALDH. 
However, Andres et al. have shown that proneuropeptide Y 
mutant bearing the Lys-Asp-Gln-Leu sequence at the car- 
boxyl terminus  is  processed  and  secreted  like  wild-type 
proneuropeptide Y when expressed in AtT-20 cells, despite 
the intraceUular retention of the unprocessed proneuropep- 
The Journal of Cell Biology, Volume  126, 1994  1418 tide Y with the Lys-Asp-Glu-Leu sequence (4), thus suggest- 
ing the important role of the acidic Glu residue in ER reten- 
tion.  We  are  now  studying  the  membrane  topology  of 
msALDH and the intracellular localization of both msALDH 
and msALDHA481-484  in more detail by immunoelectron 
microscopy to check the potential role of the tail region for 
ER retention. 
Novel ER targeting sequences have recently been reported 
for two other tail-anchored proteins.  Frangioni et al.  have 
found  that  the  ER  targeting  sequence  of protein  tyrosine 
phosphatase 1B (PTP 1B) exists within the carboxyl-terminal 
35 amino acids (12). Mitoma and Ito have shown that the last 
10  amino  acids  of  cytochrome  b5,  which  include  the 
hydrophilic tail of this protein, are important for its targeting 
to the ER (23). Fig.  12 A shows an alignment of the last 35 
amino  acids  of  PTP  1B  (9),  cytochrome  b5  (32),  and 
msALDH (24),  where each hydrophobic domain is under- 
lined and the ER-targeting  sequences of cytochrome b5 and 
msALDH are indicated by the broken line. Although the se- 
quence required for ER targeting  within the last 35 amino 
acids of PTP  1B has not been defined,  PTP  1B and cyto- 
chrome b5 have the common Leu-X-Tyr-Arg  motif (Fig.  12 
A) within their last 10 amino acids. In addition, PTP 1B and 
cytochrome b5 have tails of similar length (seven and eight 
amino acid residues,  respectively),  which are  longer than 
that  (four amino acid  residues)  of msALDH.  It therefore 
seems likely that PTP 1B possesses a similar ER-targeting 
sequence to that of cytochrome b5. We have not found in the 
carboxyl-terminal  portion of msALDH  a motif similar to 
that  in  those  two  proteins,  despite  the  fact  that  the  ER- 
targeting  sequences  of cytochrome  b5 and msALDH  are 
both hydrophilic and adjacent  to the membrane anchors. In 
addition, the presence in msALDH of two ER-targeting  se- 
quences separated by the membrane-anchoring domain sug- 
gests that this protein, with respect to the ER-targeting  se- 
quence, belongs to a different class than the other two. 
Possible Mechanisms for ER Targeting 
In addition  to the three proteins described  above,  several 
other  ER  membrane  proteins  are  known  that  also  have 
carboxyl-terminal anchors, such as heine oxygenase (40) and 
ribosome-binding  protein  p34  (28),  but  ER-targeting  se- 
quences  of  these  proteins  have  not  yet  been  identified. 
Cytochrome bS, heme oxygenase, and msALDH are synthe- 
sized on free polysomes (29, 41, 45) and posttranslationally 
targeted to the ER. Indeed, the SRP-independent integration 
of cytochrome  b5  into  microsomal  membranes  has  been 
demonstrated  (3).  Our  present  study,  together  with these 
findings, suggests a novel pathway by which a class of tail- 
anchored proteins with a novel targeting  sequence is directed 
to the ER. 
How might the ER-targeting  sequence function?  Fig. 12 B 
shows two possible models to explain the ER targeting  of 
msALDH. One possibility (/) is that the hydrophilic target- 
ing sequences serve to prevent the aggregation of the newly 
synthesized msALDH polypeptides through their hydropho- 
bic anchoring  sequences,  which makes  it easier for them 
finding a. specific receptor on the ER membrane.  Another 
possibility (I/) is that a cytosolic receptor binds to the target- 
ing sequences of msALDH to form a complex that effects the 
correct insertion of the carboxyl-terminal anchor into the ER 
membrane spontaneously or through their interactions with 
a receptor on the membrane. The elucidation of the mecha- 
nisms by which ER localization of msALDH occurs should 
provide valuable clues for an understanding of the posttrans- 
lational targeting and insertion of a class of membrane pro- 
teins with a carboxyl-terminal anchor. 
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